Hayashi, T.; Sano, K.; Okada, M.; Muto, M.; Konishi, I.
Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer. Curr. Oncol. 2024, 31, 6723-6734.
https://doi.org/10.3390/curroncol31110496
AMA Style
Hayashi T, Sano K, Okada M, Muto M, Konishi I.
Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer. Current Oncology. 2024; 31(11):6723-6734.
https://doi.org/10.3390/curroncol31110496
Chicago/Turabian Style
Hayashi, Takuma, Kenji Sano, Mako Okada, Manabu Muto, and Ikuo Konishi.
2024. "Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer" Current Oncology 31, no. 11: 6723-6734.
https://doi.org/10.3390/curroncol31110496
APA Style
Hayashi, T., Sano, K., Okada, M., Muto, M., & Konishi, I.
(2024). Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer. Current Oncology, 31(11), 6723-6734.
https://doi.org/10.3390/curroncol31110496